Medical Probiotics Market Synopsis:
Medical Probiotics Market Size Was Valued at USD 87.72 Billion in 2023, and is Projected to Reach USD 289.80 Billion by 2032, Growing at a CAGR of 14.20 % From 2024-2032.
Medical Probiotics Market can be define as the sector of the healthcare industry that relates to separate types of probiotic products pertaining to a medical need. These probiotics are known to be live bacteria that positively affect the human body when taken in right measures. Probiotics are consumed in cases where an individual’s gut flora balance needs to be kept optimum, or in managing specific disorders of the gastrointestinal tract and other related conditions. Medical probiotics are in capsule, tablet, powder, liquid form, and are ordered or suggested by physician or other health care provider for particular medical uses.
Rising incidence of gastrointestinal diseases and growing consumer knowledge of the uses of probiotics are key factors that will fuel the medical probiotics market. Gut health issues including IBS, constipation and diarrhea are increasing in occurrence worldwide, consequently creating market demand for probiotics. In addition, consumer knowledge follows the functions of probiotics in maintaining gut and immune system health and the relevance to their well-being, which also adds to market progression.
Also, the increase in the consumption of preventive medicine and the increase in the use of medical probiotics are also driving this market. This leaves pharmacologists focusing on natural products with little or no side effects such as probiotics, known and trusted by consumers. This, together with the availability of an increasing range of probiotics in pharmacies and other online shops, further drives the market ahead.
Medical Probiotics Market Trend Analysis:
Increased popularity
-
With regards to the features of the medical probiotics market, one can single out the trend of the increased popularity of the so-called ‘specialist’ probiotics that have certain therapeutic effects. Today’s consumers are interested in very targeted Probiotic products, whether it be for digestive issues or immune support or oral. Therefore, manufacturers are striving to create specific probiotic formulations for these specific purposes.
- The final human pertaining trend is what could referred to as the market targeting trend, where probiotics are being marketed as being suitable for specific health profiles. In the future technological concerns of the genomics and personalized medicine have made the consumer interested in the specific probiotics for their condition. This we believe is expected to enhance innovation and personalization within the medical probiotics niche.
Continuously growing demand for probiotics
-
The prospects of industry include the continuously growing demand for probiotics in the new markets. As for the geographical side, Asia Pacific, Latin America, and the Middle East, have increasing demands for probiotics and a growing middle-class population interested in healthy food and beverages. As such it provides a tremendous opportunity for companies to grow and be able to satisfy these new markets.
- Third, there is also a rising trend in the use of synbiotics and other therapeutic applications of probiotics provide further opportunity. For instance, the combination of the probiotics with prebiotics and other functional ingredients, such as fibers or vitamins, results in the creation of new products with the increased level of health positive impact. Such combination could be attractive to the consumers with interest in acquiring ‘jacks of all trades’ items and may also contribute to the development of the market.
Medical Probiotics Market Segment Analysis:
Medical Probiotics Market is Segmented on the basis of Product Type, Application, End-User, and Region
By Product Type, Capsules segment is expected to dominate the market during the forecast period
-
The Medical Probiotics Market by product form includes capsules and tablets and powder and liquid and others. The most familiar preparations are capsules and tablets because of the ease of administration and possibility of accurate dosing. In the same way, powdered probiotics have become common since many people like taking them dissolved in fluids or other foods. Liquid probiotics is favored by some consumers, especially those who have a problem in swallowing pills or those who wanted faster release. The “other” segment looks at the different probiotic-based items that exist such as chewable tablets and foods that have probiotics in them.
By Application, Gastrointestinal Disorders segment expected to held the largest share
-
Since, Medical Probiotics is consumed for various health conditions, it can be used for gastrointestinal disorders, oral health, immune system disorders, allergic diseases, respiratory infections, urogenital disorders and other conditions. Recent data reveal that probiotics are used in the management of conditions such as irritable bowel syndrome, constipation, and diarrhoea. At the same time, probiotics have established themselves not only as aids in maintaining good digestion but as helpers in oral health, immunity, allergies, and respiratory diseases. They are being used to treat other urogenital conditions, especially UTIs, and the use is becoming more popular.
Medical Probiotics Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
-
North America occupies the largest market share in the medical probiotics market today. The region has a mandatory system of healthcare, a high level of awareness, and a great availability of prognostic products. Probiotics as an important supplement for maintaining gut health and immune strength as well as the trend towards preventive care also contribute to the region’s adherence. Favorably further, the availability of primary producers and a robust selling network also supports the market in North America.
- Additionally, North American market has a favorable regulatory policy to govern use, safety and efficacy of the probiotics in the market. This has helped to fuel the increasing use of probiotics for medical reasons especially in the United States and Canada. The desire for natural and organic products and solutions for one’s health, and the continually rising importance of healthy lifestyles, should further boost this regional demand.
Active Key Players in the Medical Probiotics Market:
-
BASF SE (Germany)
- BioGaia AB (Sweden)
- Chr. Hansen (Denmark)
- Danone (France)
- DSM Nutritional Products (Netherlands)
- Lallemand Inc. (Canada)
- Nestlé Health Science (Switzerland)
- Pfizer Inc. (USA)
- Probi AB (Sweden)
- Yakult Honsha Co., Ltd. (Japan)
- Other Active Players
|
Global Medical Probiotics Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 87.72 Billion |
|
Forecast Period 2024-32 CAGR: |
14.20 % |
Market Size in 2032: |
USD 289.80 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Medical Probiotics Market by Product Type
4.1 Medical Probiotics Market Snapshot and Growth Engine
4.2 Medical Probiotics Market Overview
4.3 Capsules
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Capsules: Geographic Segmentation Analysis
4.4 Tablets
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Tablets: Geographic Segmentation Analysis
4.5 Powder
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Powder: Geographic Segmentation Analysis
4.6 Liquid
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Liquid: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Others: Geographic Segmentation Analysis
Chapter 5: Medical Probiotics Market by Application
5.1 Medical Probiotics Market Snapshot and Growth Engine
5.2 Medical Probiotics Market Overview
5.3 Gastrointestinal Disorders
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Gastrointestinal Disorders: Geographic Segmentation Analysis
5.4 Oral Health
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Oral Health: Geographic Segmentation Analysis
5.5 Immune System Disorders
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Immune System Disorders: Geographic Segmentation Analysis
5.6 Allergic Diseases
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Allergic Diseases: Geographic Segmentation Analysis
5.7 Respiratory Infections
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Respiratory Infections: Geographic Segmentation Analysis
5.8 Urogenital Disorders
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Urogenital Disorders: Geographic Segmentation Analysis
5.9 Others
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Others: Geographic Segmentation Analysis
Chapter 6: Medical Probiotics Market by End User
6.1 Medical Probiotics Market Snapshot and Growth Engine
6.2 Medical Probiotics Market Overview
6.3 Adults
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Adults: Geographic Segmentation Analysis
6.4 Infants
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Infants: Geographic Segmentation Analysis
6.5 Elderly
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Elderly: Geographic Segmentation Analysis
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Medical Probiotics Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 DANONE (FRANCE)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 NESTLÉ HEALTH SCIENCE (SWITZERLAND)
7.4 CHR. HANSEN (DENMARK)
7.5 PROBI AB (SWEDEN)
7.6 LALLEMAND INC. (CANADA)
7.7 YAKULT HONSHA CO. LTD. (JAPAN)
7.8 PFIZER INC. (USA)
7.9 DSM NUTRITIONAL PRODUCTS (NETHERLANDS)
7.10 BASF SE (GERMANY)
7.11 BIOGAIA AB (SWEDEN)
7.12 OTHER ACTIVE PLAYERS
Chapter 8: Global Medical Probiotics Market By Region
8.1 Overview
8.2. North America Medical Probiotics Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Product Type
8.2.4.1 Capsules
8.2.4.2 Tablets
8.2.4.3 Powder
8.2.4.4 Liquid
8.2.4.5 Others
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Gastrointestinal Disorders
8.2.5.2 Oral Health
8.2.5.3 Immune System Disorders
8.2.5.4 Allergic Diseases
8.2.5.5 Respiratory Infections
8.2.5.6 Urogenital Disorders
8.2.5.7 Others
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Adults
8.2.6.2 Infants
8.2.6.3 Elderly
8.2.6.4 Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Medical Probiotics Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Product Type
8.3.4.1 Capsules
8.3.4.2 Tablets
8.3.4.3 Powder
8.3.4.4 Liquid
8.3.4.5 Others
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Gastrointestinal Disorders
8.3.5.2 Oral Health
8.3.5.3 Immune System Disorders
8.3.5.4 Allergic Diseases
8.3.5.5 Respiratory Infections
8.3.5.6 Urogenital Disorders
8.3.5.7 Others
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Adults
8.3.6.2 Infants
8.3.6.3 Elderly
8.3.6.4 Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Medical Probiotics Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Product Type
8.4.4.1 Capsules
8.4.4.2 Tablets
8.4.4.3 Powder
8.4.4.4 Liquid
8.4.4.5 Others
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Gastrointestinal Disorders
8.4.5.2 Oral Health
8.4.5.3 Immune System Disorders
8.4.5.4 Allergic Diseases
8.4.5.5 Respiratory Infections
8.4.5.6 Urogenital Disorders
8.4.5.7 Others
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Adults
8.4.6.2 Infants
8.4.6.3 Elderly
8.4.6.4 Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Medical Probiotics Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Product Type
8.5.4.1 Capsules
8.5.4.2 Tablets
8.5.4.3 Powder
8.5.4.4 Liquid
8.5.4.5 Others
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Gastrointestinal Disorders
8.5.5.2 Oral Health
8.5.5.3 Immune System Disorders
8.5.5.4 Allergic Diseases
8.5.5.5 Respiratory Infections
8.5.5.6 Urogenital Disorders
8.5.5.7 Others
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Adults
8.5.6.2 Infants
8.5.6.3 Elderly
8.5.6.4 Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Medical Probiotics Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Product Type
8.6.4.1 Capsules
8.6.4.2 Tablets
8.6.4.3 Powder
8.6.4.4 Liquid
8.6.4.5 Others
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Gastrointestinal Disorders
8.6.5.2 Oral Health
8.6.5.3 Immune System Disorders
8.6.5.4 Allergic Diseases
8.6.5.5 Respiratory Infections
8.6.5.6 Urogenital Disorders
8.6.5.7 Others
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Adults
8.6.6.2 Infants
8.6.6.3 Elderly
8.6.6.4 Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Medical Probiotics Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Product Type
8.7.4.1 Capsules
8.7.4.2 Tablets
8.7.4.3 Powder
8.7.4.4 Liquid
8.7.4.5 Others
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Gastrointestinal Disorders
8.7.5.2 Oral Health
8.7.5.3 Immune System Disorders
8.7.5.4 Allergic Diseases
8.7.5.5 Respiratory Infections
8.7.5.6 Urogenital Disorders
8.7.5.7 Others
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Adults
8.7.6.2 Infants
8.7.6.3 Elderly
8.7.6.4 Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
|
Global Medical Probiotics Market |
|||
|
Base Year: |
2023 |
Forecast Period: |
2024-2032 |
|
Historical Data: |
2017 to 2023 |
Market Size in 2023: |
USD 87.72 Billion |
|
Forecast Period 2024-32 CAGR: |
14.20 % |
Market Size in 2032: |
USD 289.80 Billion |
|
Segments Covered: |
By Product Type |
|
|
|
By Application |
|
||
|
By End-User |
|
||
|
By Region |
|
||
|
Key Market Drivers: |
|
||
|
Key Market Restraints: |
|
||
|
Key Opportunities: |
|
||
|
Companies Covered in the report: |
|
||
